James S. Arthurs
Geschäftsführer bei Armune BioScience, Inc.
Profil
James S.
Arthurs is currently the Chief Operating Officer at Armune BioScience, Inc. He previously worked as a Principal at the FDA Alumni Association and CLIA, Inc. He completed his undergraduate degree at The Pennsylvania State University.
Aktive Positionen von James S. Arthurs
| Unternehmen | Position | Beginn |
|---|---|---|
Armune BioScience, Inc.
 Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Geschäftsführer | - |
Ehemalige bekannte Positionen von James S. Arthurs
| Unternehmen | Position | Ende |
|---|---|---|
| CLIA, Inc. | Corporate Officer/Principal | - |
| FDA Alumni Association | Corporate Officer/Principal | - |
Ausbildung von James S. Arthurs
| The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Health Services |
| FDA Alumni Association | |
| CLIA, Inc. |
